GLP-1 weight loss patches reduced cravings during a month-long trial but caused no weight loss and remain unapproved by the ...

People searching for an affordable way to lose weight with a GLP-1 drug may come across products marketed as “GLP-1 patches” online. They’re advertised as helping to reduce cravings, control appetite ...

Glucagon-like peptide-1 receptor agonists (GLP-1s) have become well known for their significant role as an aid in weight loss ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

Anodyne Nanotech Inc., a clinical-stage biotechnology company simplifying chronic care through transdermal delivery, today ...

Several of the products HT found on the e-commerce websites are not competing products so much as the same formulation ...

Anodyne Nanotech announced today that it closed a $12.6 million Series A financing to support its transdermal drug delivery technology.

According to a 2025 Kaiser Family Foundation poll, one in eight adults in the U.S. are currently taking a GLP-1 medication. This number has probably increased even more since the poll was conducted, ...

Toronto, Ontario--(Newsfile Corp. - January 14, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the ...

PatchAura, a growing name in wearable wellness, expands its product line with five new wellness patches designed to support common daily wellness goals. The additions include a NAD+ patch, hydration ...